Status:
WITHDRAWN
T2 Heart Mapping in AMI Population for the Prediction of Short Term Major Adverse Cardiovascular Events
Lead Sponsor:
University of Arizona
Conditions:
Myocardial Infarction, Acute
Eligibility:
All Genders
18-89 years
Brief Summary
A novel Cardiac MRI sequence, developed by Dr. Maria Altbach (Double Inversion radial fast Spin Echo T2 mapping), has been tested clinically. It demonstrated a high sensitivity to the heart muscle swe...
Detailed Description
In the initial feasibility project, a novel Cardiac MRI sequence (Double Inversion radial fast Spin Echo T2 mapping)developed by Dr. Maria Altbach at the University of Arizona, has been tested clinica...
Eligibility Criteria
Inclusion
- between 18 to 89 years old
- diagnosis of Acute MI
- clinically
Exclusion
- contraindications for contrast enhanced CMR
- acute congestive heart failure
- ventricular or atrial arrhythmias
- ongoing chest pain/unstable angina
- ECG changes suggestive of acute/ongoing ischemia
- hypotension with systolic blood pressure \<100 mmHg
- severe hypertension despite therapy, with systolic BP\>180 mmHg,
- Patients without a telephone number and/or address for follow up
- Patients with severe claustrophobia.
- Vulnerable populations, such as minors, pregnant women, prisoners, or cognitively impaired patients
Key Trial Info
Start Date :
February 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01796743
Start Date
February 1 2013
End Date
December 1 2015
Last Update
February 8 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Arizona
Tucson, Arizona, United States, 85724